Literature DB >> 18501351

Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.

Heiko Braak1, Kelly Del Tredici.   

Abstract

The classical model of the cortico-basal ganglia-cortical circuit, with its indirect and direct pathways, was developed to explain the phenomenon of hypokinesia in Parkinson's disease (PD). The model has undergone refinement, but the emphasis on the basal ganglia side of the equation (dopamine deficiency in the dorsal striatum) remains. Here, a revised version of the basic model incorporates key non-dopaminergic connectivities known to become affected in the course of PD and, thus, the cortico-basal ganglia-cortical circuit appears within the context of the larger pathological process. The central roles of the corticostriatal projection, corticosubthalamic projection, and lower brainstem nuclei are emphasized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501351     DOI: 10.1016/j.expneurol.2008.04.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

1.  Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Harrison C Walker; He Huang; Christopher L Gonzalez; James E Bryant; Jeffrey Killen; Gary R Cutter; Robert C Knowlton; Erwin B Montgomery; Bart L Guthrie; Ray L Watts
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

2.  Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

Authors:  Noemí Fabelo; Virginia Martín; Gabriel Santpere; Raquel Marín; Laia Torrent; Isidre Ferrer; Mario Díaz
Journal:  Mol Med       Date:  2011-06-22       Impact factor: 6.354

Review 3.  Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson's disease.

Authors:  Emily K Plowman; Jeffrey A Kleim
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

4.  On the Role of Cortex-Basal Ganglia Interactions for Category Learning: A Neurocomputational Approach.

Authors:  Francesc Villagrasa; Javier Baladron; Julien Vitay; Henning Schroll; Evan G Antzoulatos; Earl K Miller; Fred H Hamker
Journal:  J Neurosci       Date:  2018-09-18       Impact factor: 6.167

Review 5.  Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Authors:  David Lindenbach; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2013-10-07       Impact factor: 8.989

Review 6.  Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease.

Authors:  Shichun Peng; David Eidelberg; Yilong Ma
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

Review 7.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

Review 8.  The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability.

Authors:  Eugenio Scarnati; Tiziana Florio; Annamaria Capozzo; Giuseppina Confalone; Paolo Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 9.  Our first decade of experience in deep brain stimulation of the brainstem: elucidating the mechanism of action of stimulation of the ventrolateral pontine tegmentum.

Authors:  Paolo Mazzone; Osvaldo Vilela Filho; Fabio Viselli; Angelo Insola; Stefano Sposato; Flora Vitale; Eugenio Scarnati
Journal:  J Neural Transm (Vienna)       Date:  2016-02-11       Impact factor: 3.575

Review 10.  A dual-hit animal model for age-related parkinsonism.

Authors:  Heather A Boger; Ann-Charlotte Granholm; Jacqueline F McGinty; Lawrence D Middaugh
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.